Picture loading failed.

Document

About GeneMedi (GM)


We develop solutions for
the therapeutics and diagnostics industry.

Picture loading failed.
Picture loading failed.




About GMoleTM

GMolecule-Innovative capabilities in molecular entity discovery and application development.
GMolecule is the capabilities derived from insight and expertise of Gene & Biologics molecular entity discovery and development. Our QbD process is combined and optimized with intelligent design, smart discovery, rational development, and State-of-the-Art manufacturing (D&D&D&M). Data management is separated independently for high-quality data certification. The modalities and facilities of GMolecule are including antibodies, recombinant protein, and multiple types of gene therapy vectors and delivery vehicles (AAV, lentivirus, virus-like particle(VLP), etc.).

About GTU&GDU

GTU&GDU, GeneMedi Therapeutics Unit & GeneMedi Diagnostics Unit, are GM's 2 unique product-solution units for the industry of therapeutics or diagnostics. Since the insight from GM’s unique in-house database-GM target/biomarkers and diseases database, GM empowers self-capabilities for application development to develop more effective products and solutions to meet the needs of the therapeutics and diagnostics industry.

Picture loading failed.    Picture loading failed.

About GeneMedi ITD

ITD is GeneMedi’s target-insight database that connects human indications/diseases/conditions with associated targets/biomarkers in diagnostics, therapeutics, and prognostics. ITD is a data-driven artificial intelligent system that learns from literature and in-house wet-dry exploration with closed-loop design. GeneMedi ITD target-insight system robustly improves the development efficiency for therapeutics and diagnostics industry solutions.



GeneMedi BGM-XTM Innovative Engine

Picture loading failed.

With years of modalities discovery insight and expertise in the pharmaceutical industry, GeneMedi has developed innovative BGM-XTM Engine for big data-driven scientific discovery and industrial development in modalities of biologics and gene therapeutics.

Picture loading failed.